Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Eriksson

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Genetics|January 18, 2005
MLH1 and MSH2 promote the symmetry of double-strand break repair events at the HIS4 hotspot in Saccharomyces cerevisiaeEva R Hoffmann, Emma Eriksson, Benjamin J Herbert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2019
IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1Emma Eriksson, Ioanna Milenova, Jessica Wenthe, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|October 21, 2011
Quantification of cell volume changes upon hyperosmotic stress in Saccharomyces cerevisiaeElzbieta Petelenz-Kurdziel, Emma Eriksson, Maria Smedh, et al.
Plos One|December 11, 2012
Bortezomib is cytotoxic to the human growth plate and permanently impairs bone growth in young miceEmma Eriksson, Farasat Zaman, Dionisios Chrysis, et al.
Infection and Immunity|June 24, 2003
CD44-regulated intracellular proliferation of Listeria monocytogenesEmma Eriksson, Lone Dons, Antonio Gigliotti Rothfuchs, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2002
Immunogenic regions of the GA733-2 tumour-associated antigen recognised by autoantibodies of patients with colorectal carcinomaSzilvia Mosolits, Michael Steinitz, Ulrika Harmenberg, et al.
Cancer Gene Therapy|May 2, 2020
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40Jessica Wenthe, Sedigheh Naseri, Ann-Charlotte Hellström, et al.
Molecular Cancer|June 22, 2014
Bortezomib treatment causes long-term testicular dysfunction in young male miceMi Hou, Emma Eriksson, Konstantin Svechnikov, et al.
Journal of Nanoscience and Nanotechnology|March 12, 2008
Dielectrophoresis-induced separation of metallic and semiconducting single-wall carbon nanotubes in a continuous flow microfluidic systemMattias Mattsson, Andrei Gromov, Staffan Dittmer, et al.
Journal of the National Cancer Institute|March 4, 2014
Protective role of humanin on bortezomib-induced bone growth impairment in anticancer treatmentEmma Eriksson, Malin Wickström, Lova Segerström Perup, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Genetics|January 18, 2005
MLH1 and MSH2 promote the symmetry of double-strand break repair events at the HIS4 hotspot in Saccharomyces cerevisiaeEva R Hoffmann, Emma Eriksson, Benjamin J Herbert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2019
IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1Emma Eriksson, Ioanna Milenova, Jessica Wenthe, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|October 21, 2011
Quantification of cell volume changes upon hyperosmotic stress in Saccharomyces cerevisiaeElzbieta Petelenz-Kurdziel, Emma Eriksson, Maria Smedh, et al.
Plos One|December 11, 2012
Bortezomib is cytotoxic to the human growth plate and permanently impairs bone growth in young miceEmma Eriksson, Farasat Zaman, Dionisios Chrysis, et al.
Infection and Immunity|June 24, 2003
CD44-regulated intracellular proliferation of Listeria monocytogenesEmma Eriksson, Lone Dons, Antonio Gigliotti Rothfuchs, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2002
Immunogenic regions of the GA733-2 tumour-associated antigen recognised by autoantibodies of patients with colorectal carcinomaSzilvia Mosolits, Michael Steinitz, Ulrika Harmenberg, et al.
Cancer Gene Therapy|May 2, 2020
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40Jessica Wenthe, Sedigheh Naseri, Ann-Charlotte Hellström, et al.
Molecular Cancer|June 22, 2014
Bortezomib treatment causes long-term testicular dysfunction in young male miceMi Hou, Emma Eriksson, Konstantin Svechnikov, et al.
Journal of Nanoscience and Nanotechnology|March 12, 2008
Dielectrophoresis-induced separation of metallic and semiconducting single-wall carbon nanotubes in a continuous flow microfluidic systemMattias Mattsson, Andrei Gromov, Staffan Dittmer, et al.
Journal of the National Cancer Institute|March 4, 2014
Protective role of humanin on bortezomib-induced bone growth impairment in anticancer treatmentEmma Eriksson, Malin Wickström, Lova Segerström Perup, et al.
Pageof 5